SEC Form 4 · accession 0001209191-17-047517
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Aug 2, 2017
Accepted (ET)
Aug 3, 2017 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Aug 2, 2017 | S | 10,000 | $51.7883 | D | 87,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common StockF2 | holding | — | — | — | 118,251 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $51.37 to $52.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2Shares held following the reported transactions include 118,251 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.